Data from Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype Article Swipe
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/2326-6066.c.6550338.v1
The interplay between cancer cells and immune cells is a key determinant of tumor survival. Here, we uncovered how tumors exploit the immunomodulatory properties of the extracellular matrix to create a microenvironment that enables their escape from immune surveillance. Using orthotopic grafting of mammary tumor cells in immunocompetent mice and autochthonous models of breast cancer, we discovered how tenascin-C, a matrix molecule absent from most healthy adult tissues but expressed at high levels and associated with poor patient prognosis in many solid cancers, controls the immune status of the tumor microenvironment. We found that, although host-derived tenascin-C promoted immunity via recruitment of proinflammatory, antitumoral macrophages, tumor-derived tenascin-C subverted host defense by polarizing tumor-associated macrophages toward a pathogenic, immune-suppressive phenotype. Therapeutic monoclonal antibodies that blocked tenascin-C activation of Toll-like receptor 4 reversed this phenotypic switch in vitro and reduced tumor growth and lung metastasis in vivo, providing enhanced benefit in combination with anti–PD-L1 over either treatment alone. Combined tenascin-C:macrophage gene-expression signatures delineated a significant survival benefit in people with breast cancer. These data revealed a new approach to targeting tumor-specific macrophage polarization that may be effective in controlling the growth and spread of breast tumors.
Related Topics
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/2326-6066.c.6550338.v1
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4362546802
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4362546802Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/2326-6066.c.6550338.v1Digital Object Identifier
- Title
-
Data from Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage PhenotypeWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-04-04Full publication date if available
- Authors
-
Claire Deligne, Devadarssen Murdamoothoo, Anís N. Gammage, Martha Gschwandtner, William Erne, Thomas Loustau, Anna M. Marzeda, Raphaël Carapito, Nicodème Paul, Inés Velázquez-Quesada, Imogen Mazzier, Zhen Sun, Gertraud Orend, Kim S. MidwoodList of authors in order
- Landing page
-
https://doi.org/10.1158/2326-6066.c.6550338.v1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/2326-6066.c.6550338.v1Direct OA link when available
- Concepts
-
Tenascin C, Tumor microenvironment, Immune system, Cancer research, Macrophage polarization, Tenascin, Biology, Macrophage, Immunology, Mammary tumor, Immunotherapy, Metastasis, Extracellular matrix, M2 Macrophage, Breast cancer, Cancer, Cell biology, In vitro, Fibronectin, Genetics, BiochemistryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4362546802 |
|---|---|
| doi | https://doi.org/10.1158/2326-6066.c.6550338.v1 |
| ids.doi | https://doi.org/10.1158/2326-6066.c.6550338.v1 |
| ids.openalex | https://openalex.org/W4362546802 |
| fwci | 0.0 |
| type | preprint |
| title | Data from Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10831 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9995999932289124 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2723 |
| topics[0].subfield.display_name | Immunology and Allergy |
| topics[0].display_name | Cell Adhesion Molecules Research |
| topics[1].id | https://openalex.org/T10580 |
| topics[1].field.id | https://openalex.org/fields/24 |
| topics[1].field.display_name | Immunology and Microbiology |
| topics[1].score | 0.9950000047683716 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2403 |
| topics[1].subfield.display_name | Immunology |
| topics[1].display_name | Immunotherapy and Immune Responses |
| topics[2].id | https://openalex.org/T11131 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9940999746322632 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1307 |
| topics[2].subfield.display_name | Cell Biology |
| topics[2].display_name | Proteoglycans and glycosaminoglycans research |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C117961784 |
| concepts[0].level | 3 |
| concepts[0].score | 0.7171778678894043 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q18027461 |
| concepts[0].display_name | Tenascin C |
| concepts[1].id | https://openalex.org/C2776107976 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6718810796737671 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1786433 |
| concepts[1].display_name | Tumor microenvironment |
| concepts[2].id | https://openalex.org/C8891405 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6160896420478821 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[2].display_name | Immune system |
| concepts[3].id | https://openalex.org/C502942594 |
| concepts[3].level | 1 |
| concepts[3].score | 0.608243465423584 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[3].display_name | Cancer research |
| concepts[4].id | https://openalex.org/C2776682551 |
| concepts[4].level | 4 |
| concepts[4].score | 0.5239108800888062 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q21072584 |
| concepts[4].display_name | Macrophage polarization |
| concepts[5].id | https://openalex.org/C2777738151 |
| concepts[5].level | 4 |
| concepts[5].score | 0.5114220976829529 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1903925 |
| concepts[5].display_name | Tenascin |
| concepts[6].id | https://openalex.org/C86803240 |
| concepts[6].level | 0 |
| concepts[6].score | 0.5079799294471741 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[6].display_name | Biology |
| concepts[7].id | https://openalex.org/C2779244956 |
| concepts[7].level | 3 |
| concepts[7].score | 0.5023362636566162 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q184204 |
| concepts[7].display_name | Macrophage |
| concepts[8].id | https://openalex.org/C203014093 |
| concepts[8].level | 1 |
| concepts[8].score | 0.49099162220954895 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[8].display_name | Immunology |
| concepts[9].id | https://openalex.org/C2776187077 |
| concepts[9].level | 4 |
| concepts[9].score | 0.4618372917175293 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q1888235 |
| concepts[9].display_name | Mammary tumor |
| concepts[10].id | https://openalex.org/C2777701055 |
| concepts[10].level | 3 |
| concepts[10].score | 0.45780158042907715 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q1427096 |
| concepts[10].display_name | Immunotherapy |
| concepts[11].id | https://openalex.org/C2779013556 |
| concepts[11].level | 3 |
| concepts[11].score | 0.4571218192577362 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q181876 |
| concepts[11].display_name | Metastasis |
| concepts[12].id | https://openalex.org/C189165786 |
| concepts[12].level | 2 |
| concepts[12].score | 0.4498414993286133 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q193825 |
| concepts[12].display_name | Extracellular matrix |
| concepts[13].id | https://openalex.org/C2910375186 |
| concepts[13].level | 4 |
| concepts[13].score | 0.42692068219184875 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q184204 |
| concepts[13].display_name | M2 Macrophage |
| concepts[14].id | https://openalex.org/C530470458 |
| concepts[14].level | 3 |
| concepts[14].score | 0.3924100399017334 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q128581 |
| concepts[14].display_name | Breast cancer |
| concepts[15].id | https://openalex.org/C121608353 |
| concepts[15].level | 2 |
| concepts[15].score | 0.3504064083099365 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[15].display_name | Cancer |
| concepts[16].id | https://openalex.org/C95444343 |
| concepts[16].level | 1 |
| concepts[16].score | 0.14583027362823486 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q7141 |
| concepts[16].display_name | Cell biology |
| concepts[17].id | https://openalex.org/C202751555 |
| concepts[17].level | 2 |
| concepts[17].score | 0.1358310878276825 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q221681 |
| concepts[17].display_name | In vitro |
| concepts[18].id | https://openalex.org/C86492073 |
| concepts[18].level | 3 |
| concepts[18].score | 0.07937803864479065 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q413766 |
| concepts[18].display_name | Fibronectin |
| concepts[19].id | https://openalex.org/C54355233 |
| concepts[19].level | 1 |
| concepts[19].score | 0.0 |
| concepts[19].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[19].display_name | Genetics |
| concepts[20].id | https://openalex.org/C55493867 |
| concepts[20].level | 1 |
| concepts[20].score | 0.0 |
| concepts[20].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[20].display_name | Biochemistry |
| keywords[0].id | https://openalex.org/keywords/tenascin-c |
| keywords[0].score | 0.7171778678894043 |
| keywords[0].display_name | Tenascin C |
| keywords[1].id | https://openalex.org/keywords/tumor-microenvironment |
| keywords[1].score | 0.6718810796737671 |
| keywords[1].display_name | Tumor microenvironment |
| keywords[2].id | https://openalex.org/keywords/immune-system |
| keywords[2].score | 0.6160896420478821 |
| keywords[2].display_name | Immune system |
| keywords[3].id | https://openalex.org/keywords/cancer-research |
| keywords[3].score | 0.608243465423584 |
| keywords[3].display_name | Cancer research |
| keywords[4].id | https://openalex.org/keywords/macrophage-polarization |
| keywords[4].score | 0.5239108800888062 |
| keywords[4].display_name | Macrophage polarization |
| keywords[5].id | https://openalex.org/keywords/tenascin |
| keywords[5].score | 0.5114220976829529 |
| keywords[5].display_name | Tenascin |
| keywords[6].id | https://openalex.org/keywords/biology |
| keywords[6].score | 0.5079799294471741 |
| keywords[6].display_name | Biology |
| keywords[7].id | https://openalex.org/keywords/macrophage |
| keywords[7].score | 0.5023362636566162 |
| keywords[7].display_name | Macrophage |
| keywords[8].id | https://openalex.org/keywords/immunology |
| keywords[8].score | 0.49099162220954895 |
| keywords[8].display_name | Immunology |
| keywords[9].id | https://openalex.org/keywords/mammary-tumor |
| keywords[9].score | 0.4618372917175293 |
| keywords[9].display_name | Mammary tumor |
| keywords[10].id | https://openalex.org/keywords/immunotherapy |
| keywords[10].score | 0.45780158042907715 |
| keywords[10].display_name | Immunotherapy |
| keywords[11].id | https://openalex.org/keywords/metastasis |
| keywords[11].score | 0.4571218192577362 |
| keywords[11].display_name | Metastasis |
| keywords[12].id | https://openalex.org/keywords/extracellular-matrix |
| keywords[12].score | 0.4498414993286133 |
| keywords[12].display_name | Extracellular matrix |
| keywords[13].id | https://openalex.org/keywords/m2-macrophage |
| keywords[13].score | 0.42692068219184875 |
| keywords[13].display_name | M2 Macrophage |
| keywords[14].id | https://openalex.org/keywords/breast-cancer |
| keywords[14].score | 0.3924100399017334 |
| keywords[14].display_name | Breast cancer |
| keywords[15].id | https://openalex.org/keywords/cancer |
| keywords[15].score | 0.3504064083099365 |
| keywords[15].display_name | Cancer |
| keywords[16].id | https://openalex.org/keywords/cell-biology |
| keywords[16].score | 0.14583027362823486 |
| keywords[16].display_name | Cell biology |
| keywords[17].id | https://openalex.org/keywords/in-vitro |
| keywords[17].score | 0.1358310878276825 |
| keywords[17].display_name | In vitro |
| keywords[18].id | https://openalex.org/keywords/fibronectin |
| keywords[18].score | 0.07937803864479065 |
| keywords[18].display_name | Fibronectin |
| language | en |
| locations[0].id | doi:10.1158/2326-6066.c.6550338.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/2326-6066.c.6550338.v1 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5061322603 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-1806-5123 |
| authorships[0].author.display_name | Claire Deligne |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Claire Deligne |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5076839763 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-6939-312X |
| authorships[1].author.display_name | Devadarssen Murdamoothoo |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Devadarssen Murdamoothoo |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5043248384 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-7493-8988 |
| authorships[2].author.display_name | Anís N. Gammage |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Anís N. Gammage |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5088980160 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-8869-5924 |
| authorships[3].author.display_name | Martha Gschwandtner |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Martha Gschwandtner |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5045003814 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-7305-4884 |
| authorships[4].author.display_name | William Erne |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | William Erne |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5087623059 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-4662-5228 |
| authorships[5].author.display_name | Thomas Loustau |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Thomas Loustau |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5067606739 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-5270-9797 |
| authorships[6].author.display_name | Anna M. Marzeda |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Anna M. Marzeda |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5068528684 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-7036-442X |
| authorships[7].author.display_name | Raphaël Carapito |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Raphael Carapito |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5088383728 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-4680-3012 |
| authorships[8].author.display_name | Nicodème Paul |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Nicodème Paul |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5007031587 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Inés Velázquez-Quesada |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Inés Velazquez-Quesada |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5059408377 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Imogen Mazzier |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Imogen Mazzier |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5100779928 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-7224-3592 |
| authorships[11].author.display_name | Zhen Sun |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Zhen Sun |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5010999736 |
| authorships[12].author.orcid | https://orcid.org/0000-0003-2522-1195 |
| authorships[12].author.display_name | Gertraud Orend |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Gertraud Orend |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5091304244 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-8813-2977 |
| authorships[13].author.display_name | Kim S. Midwood |
| authorships[13].author_position | last |
| authorships[13].raw_author_name | Kim S. Midwood |
| authorships[13].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/2326-6066.c.6550338.v1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Data from Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10831 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9995999932289124 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2723 |
| primary_topic.subfield.display_name | Immunology and Allergy |
| primary_topic.display_name | Cell Adhesion Molecules Research |
| related_works | https://openalex.org/W2747882396, https://openalex.org/W1964810899, https://openalex.org/W2021145609, https://openalex.org/W4242915321, https://openalex.org/W2084602170, https://openalex.org/W2145064946, https://openalex.org/W2101874377, https://openalex.org/W2073540937, https://openalex.org/W2069880945, https://openalex.org/W2039877540 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/2326-6066.c.6550338.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/2326-6066.c.6550338.v1 |
| primary_location.id | doi:10.1158/2326-6066.c.6550338.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/2326-6066.c.6550338.v1 |
| publication_date | 2023-04-04 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.4 | 129 |
| abstract_inverted_index.a | 9, 30, 59, 115, 161, 173 |
| abstract_inverted_index.We | 91 |
| abstract_inverted_index.at | 70 |
| abstract_inverted_index.be | 183 |
| abstract_inverted_index.by | 110 |
| abstract_inverted_index.in | 46, 79, 148, 165, 185 |
| abstract_inverted_index.is | 8 |
| abstract_inverted_index.of | 12, 24, 42, 52, 87, 101, 126, 191 |
| abstract_inverted_index.to | 28, 176 |
| abstract_inverted_index.we | 16, 55 |
| abstract_inverted_index.and | 5, 49, 73, 136, 140, 189 |
| abstract_inverted_index.but | 68 |
| abstract_inverted_index.how | 18, 57 |
| abstract_inverted_index.key | 10 |
| abstract_inverted_index.may | 182 |
| abstract_inverted_index.new | 174 |
| abstract_inverted_index.the | 21, 25, 84, 88, 187 |
| abstract_inverted_index.via | 99 |
| abstract_inverted_index.data | 171 |
| abstract_inverted_index.from | 36, 63 |
| abstract_inverted_index.high | 71 |
| abstract_inverted_index.host | 108 |
| abstract_inverted_index.lung | 141 |
| abstract_inverted_index.many | 80 |
| abstract_inverted_index.mice | 48 |
| abstract_inverted_index.most | 64 |
| abstract_inverted_index.over | 152 |
| abstract_inverted_index.poor | 76 |
| abstract_inverted_index.that | 32, 122, 181 |
| abstract_inverted_index.this | 131 |
| abstract_inverted_index.with | 75, 150, 167 |
| abstract_inverted_index.Here, | 15 |
| abstract_inverted_index.These | 170 |
| abstract_inverted_index.Using | 39 |
| abstract_inverted_index.adult | 66 |
| abstract_inverted_index.cells | 4, 7, 45 |
| abstract_inverted_index.found | 92 |
| abstract_inverted_index.solid | 81 |
| abstract_inverted_index.that, | 93 |
| abstract_inverted_index.their | 34 |
| abstract_inverted_index.tumor | 13, 44, 89, 138 |
| abstract_inverted_index.absent | 62 |
| abstract_inverted_index.alone. | 155 |
| abstract_inverted_index.breast | 53, 168, 192 |
| abstract_inverted_index.cancer | 3 |
| abstract_inverted_index.create | 29 |
| abstract_inverted_index.either | 153 |
| abstract_inverted_index.escape | 35 |
| abstract_inverted_index.growth | 139, 188 |
| abstract_inverted_index.immune | 6, 37, 85 |
| abstract_inverted_index.levels | 72 |
| abstract_inverted_index.matrix | 27, 60 |
| abstract_inverted_index.models | 51 |
| abstract_inverted_index.people | 166 |
| abstract_inverted_index.spread | 190 |
| abstract_inverted_index.status | 86 |
| abstract_inverted_index.switch | 133 |
| abstract_inverted_index.toward | 114 |
| abstract_inverted_index.tumors | 19 |
| abstract_inverted_index.benefit | 147, 164 |
| abstract_inverted_index.between | 2 |
| abstract_inverted_index.blocked | 123 |
| abstract_inverted_index.cancer, | 54 |
| abstract_inverted_index.cancer. | 169 |
| abstract_inverted_index.defense | 109 |
| abstract_inverted_index.enables | 33 |
| abstract_inverted_index.exploit | 20 |
| abstract_inverted_index.healthy | 65 |
| abstract_inverted_index.mammary | 43 |
| abstract_inverted_index.patient | 77 |
| abstract_inverted_index.reduced | 137 |
| abstract_inverted_index.tissues | 67 |
| abstract_inverted_index.Combined | 156 |
| abstract_inverted_index.although | 94 |
| abstract_inverted_index.approach | 175 |
| abstract_inverted_index.cancers, | 82 |
| abstract_inverted_index.controls | 83 |
| abstract_inverted_index.enhanced | 146 |
| abstract_inverted_index.grafting | 41 |
| abstract_inverted_index.immunity | 98 |
| abstract_inverted_index.molecule | 61 |
| abstract_inverted_index.promoted | 97 |
| abstract_inverted_index.receptor | 128 |
| abstract_inverted_index.revealed | 172 |
| abstract_inverted_index.reversed | 130 |
| abstract_inverted_index.survival | 163 |
| abstract_inverted_index.Toll-like | 127 |
| abstract_inverted_index.effective | 184 |
| abstract_inverted_index.expressed | 69 |
| abstract_inverted_index.interplay | 1 |
| abstract_inverted_index.prognosis | 78 |
| abstract_inverted_index.providing | 145 |
| abstract_inverted_index.subverted | 107 |
| abstract_inverted_index.survival. | 14 |
| abstract_inverted_index.targeting | 177 |
| abstract_inverted_index.treatment | 154 |
| abstract_inverted_index.uncovered | 17 |
| abstract_inverted_index.activation | 125 |
| abstract_inverted_index.antibodies | 121 |
| abstract_inverted_index.associated | 74 |
| abstract_inverted_index.delineated | 160 |
| abstract_inverted_index.discovered | 56 |
| abstract_inverted_index.macrophage | 179 |
| abstract_inverted_index.metastasis | 142 |
| abstract_inverted_index.monoclonal | 120 |
| abstract_inverted_index.orthotopic | 40 |
| abstract_inverted_index.phenotype. | 118 |
| abstract_inverted_index.phenotypic | 132 |
| abstract_inverted_index.polarizing | 111 |
| abstract_inverted_index.properties | 23 |
| abstract_inverted_index.signatures | 159 |
| abstract_inverted_index.tenascin-C | 96, 106, 124 |
| abstract_inverted_index.<i>in | 134, 143 |
| abstract_inverted_index.Therapeutic | 119 |
| abstract_inverted_index.antitumoral | 103 |
| abstract_inverted_index.combination | 149 |
| abstract_inverted_index.controlling | 186 |
| abstract_inverted_index.determinant | 11 |
| abstract_inverted_index.macrophages | 113 |
| abstract_inverted_index.pathogenic, | 116 |
| abstract_inverted_index.recruitment | 100 |
| abstract_inverted_index.significant | 162 |
| abstract_inverted_index.tenascin-C, | 58 |
| abstract_inverted_index.anti–PD-L1 | 151 |
| abstract_inverted_index.host-derived | 95 |
| abstract_inverted_index.macrophages, | 104 |
| abstract_inverted_index.polarization | 180 |
| abstract_inverted_index.autochthonous | 50 |
| abstract_inverted_index.extracellular | 26 |
| abstract_inverted_index.surveillance. | 38 |
| abstract_inverted_index.tumor-derived | 105 |
| abstract_inverted_index.tumor-specific | 178 |
| abstract_inverted_index.gene-expression | 158 |
| abstract_inverted_index.immunocompetent | 47 |
| abstract_inverted_index.vitro</i> | 135 |
| abstract_inverted_index.vivo</i>, | 144 |
| abstract_inverted_index.immunomodulatory | 22 |
| abstract_inverted_index.microenvironment | 31 |
| abstract_inverted_index.proinflammatory, | 102 |
| abstract_inverted_index.tumor-associated | 112 |
| abstract_inverted_index.microenvironment. | 90 |
| abstract_inverted_index.immune-suppressive | 117 |
| abstract_inverted_index.tenascin-C:macrophage | 157 |
| abstract_inverted_index.tumors.</p></div> | 193 |
| abstract_inverted_index.<div>Abstract<p>The | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 14 |
| citation_normalized_percentile.value | 0.24642857 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |